Aclaris Therapeutics, Inc.
ACRS
Revenue
9.21M
▲4.86M▲111.92%
3 Months ChangeAssets
220.33M
▲37.93M▲20.80%
3 Months ChangeLiabilities
64.77M
▲12.53M▲23.98%
3 Months ChangeFree Cash Flow
-20.95M
▲5.96M▲22.14%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-07
Form 10-Q
ID: 0001558370-24-011376
2024-08-07
Form 8-K
ID: 0001558370-24-011201
2024-07-16
Form 8-K
ID: 0001558370-24-009853
2024-06-07
Form 8-K
ID: 0001558370-24-009009
2024-05-07
Form 10-Q
ID: 0001558370-24-007069
2024-05-07
Form 8-K
ID: 0001558370-24-007055
2024-03-19
Form 8-K
ID: 0001558370-24-003572
2024-02-27
Form 8-K
ID: 0001558370-24-001752
2024-02-05
Form 8-K
ID: 0001558370-24-000769
2024-01-19
Form 8-K
ID: 0001558370-24-000373